Literature DB >> 15946440

Laparoscopic adjustable gastric banding prior to renal transplantation.

Virginia Newcombe1, Andrew Blanch, Guy H Slater, Amir Szold, George A Fielding.   

Abstract

End-stage renal failure is most commonly caused by the obesity-related diseases, diabetes mellitus and essential hypertension, and is best treated with renal transplantation. Obesity may contribute to poor patient and graft survival, and is an exclusion criterion in some renal transplant programs. Diet and exercise programs have not proven to be effective for weight loss before transplantation, and bariatric surgery in any form has not been used in this setting before. We report three morbidly obese patients who underwent laparoscopic adjustable gastric banding to meet the criteria for renal transplantation and subsequently were successfully transplanted.

Entities:  

Mesh:

Year:  2005        PMID: 15946440     DOI: 10.1381/0960892053723349

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

1.  Biliopancreatic diversion in a renal transplant patient.

Authors:  Maite López Deogracias; Agustin Domínguez-Diez; Rosa Palomar-Fontanet; Monica González-Noriega; E Rodrigo; G Fernández-Fresnedo; J A Zubimendi; Francisco Olmedo; Manuel Gómez-Fleitas; M Arias; Carlos Fernández-Escalante
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

2.  Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review.

Authors:  Kian A Modanlou; Umadevi Muthyala; Huiling Xiao; Mark A Schnitzler; Paolo R Salvalaggio; Daniel C Brennan; Kevin C Abbott; Ralph J Graff; Krista L Lentine
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

3.  Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis.

Authors:  Babak J Orandi; Joshua W Purvis; Robert M Cannon; A Blair Smith; Cora E Lewis; Norah A Terrault; Jayme E Locke
Journal:  Am J Surg       Date:  2020-06-13       Impact factor: 2.565

4.  Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease.

Authors:  Shadi Al-Bahri; Tannous K Fakhry; John Paul Gonzalvo; Michel M Murr
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

5.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 6.  Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Authors:  Ted D Adams; David E Arterburn; David M Nathan; Robert H Eckel
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

7.  Outcomes of laparoscopic bariatric surgery after renal transplant.

Authors:  Samuel Szomstein; Renan Rojas; Raul J Rosenthal
Journal:  Obes Surg       Date:  2009-09-25       Impact factor: 4.129

Review 8.  Obesity management in adults with CKD.

Authors:  Holly Kramer; Katherine R Tuttle; David Leehey; Amy Luke; Ramon Durazo-Arvizu; David Shoham; Richard Cooper; Srinvisan Beddhu
Journal:  Am J Kidney Dis       Date:  2009-01       Impact factor: 8.860

9.  Safety analysis of primary bariatric surgery in patients on chronic dialysis.

Authors:  Amin Andalib; Ali Aminian; Zhamak Khorgami; Sankar D Navaneethan; Philip R Schauer; Stacy A Brethauer
Journal:  Surg Endosc       Date:  2015-09-28       Impact factor: 4.584

Review 10.  Cardiovascular disease in transplant recipients: current and future treatment strategies.

Authors:  John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.